Week In Review: China Life Science Companies Raise Nearly $1 Billion Led By Legend’s $424 Million U.S. IPO

Legend Biotech priced its US IPO above the expected range at $23 per ADS, raising $424 million. Jacobio Pharma out-licensed rights for its two-molecule SHP2 pro …
( read original story …)

---